KAINOS Laboratories, Inc. announced that it expects to receive ¥435.12 million in funding from Asahi Kasei Pharma Corporation
May 12, 2019
Share
KAINOS Laboratories, Inc. (JASDAQ:4556) announced a private placement of 490,000 common shares at a price of JPY 888 per share for gross proceeds of JPY 435,120,000 on May 13, 2019. The transaction will included participation from returning investor Asahi Kasei Pharma Corporation. Post the closing of the transaction the stake of the investor will increase from 11.34288% to 21.1%. The company expects to close the transaction on May 29, 2019. The method of private placement is third part allotment. The estimated issue expenses is JPY 1,000,000. The company will pay the issue expenses for the preparation of documents such as the Securities Registration Statement, etc.
KAINOS Laboratories, Inc. is pricipally engaged in researching, developing, manufacturing and selling clinical diagnostic reagents, including biochemical diagnostic reagents such as renal function related reagents and automatic biochemical analytical reagents, immune serological test reagents such as transfusion-related reagents, allergy-related reagents, cancer marker related reagents, and other reagents.
KAINOS LABORATORIES, INC. 
